Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Zhejiang Bofay Electric Co.,Ltd. (001255.SZ)
Haining, CN
Established in 2007 and based in Jiaxing, China, Zhejiang Bofay Electric Co.,Ltd. is dedicated to the global and domestic research, development, production, and sale of polymer composite materials. The company's diverse product portfolio features a range of electrical insulation solutions, including various insulation resin series, slot wedges, laminates, insulation binding wires, tapes, and ropes, alongside mica composite insulating materials and other specialized electrical components. These crucial insulating products are integral to applications in sectors such as wind power generation, rail transportation, general and industrial motors, household and electrical appliances, new energy vehicles, and hydroelectric power generation.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.14% | -1.17% | -3.37% | -11.71% | +2.27% | +11.08% | +19.92% | -15.14% | +24.97% | +24.97% | +24.97% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Chemicals - Specialty: +4.7%+31.1% ★ Q1'26: +36.8% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+11.8% Q1'26: -150.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-4.6% Q1'26: -42.9% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+3.2% Q1'26: -4.1% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+1.8% Q1'26: -2.0% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+3.9% Q1'26: -7.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×2.08× ★ Q1'26: -3.98× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2023 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|
| Revenue |
353.53M
est: 309.00M (+14.4%)
|
311.61M
est: 309.00M (+0.8%)
|
341.06M
est: 323.00M (+5.6%)
|
447.20M
est: 399.00M (+12.1%)
|
494.00M
494.00M – 494.00M
+23.8% YoY
|
| EBITDA |
92.21M
est: 74.95M (+23.0%)
|
50.34M
est: 74.95M (-32.8%)
|
39.01M
est: 60.37M (-35.4%)
|
54.27M
est: 74.57M (-27.2%)
|
92.33M
92.33M – 92.33M
+23.8% YoY
|
| EBIT |
83.20M
est: 61.88M (+34.4%)
|
37.76M
est: 61.88M (-39.0%)
|
16.93M
est: 44.65M (-62.1%)
|
14.38M
est: 55.16M (-73.9%)
|
68.29M
68.29M – 68.29M
+23.8% YoY
|
| Net Income |
69.30M
est: 38.93M (+78.0%)
|
32.99M
est: 38.93M (-15.3%)
|
13.24M
est: 20.23M (-34.6%)
|
15.37M
est: 78.48M (-80.4%)
|
105.99M
105.99M – 105.99M
+35.1% YoY
|
| SGA |
26.60M
est: 16.99M (+56.6%)
|
38.07M
est: 16.99M (+124.1%)
|
44.26M
est: 30.50M (+45.1%)
|
36.95M
est: 37.67M (-1.9%)
|
46.64M
46.64M – 46.64M
+23.8% YoY
|
| EPS |
1.07
est: 0.50 (+114.0%)
|
0.41
est: 0.50 (-18.0%)
|
0.17
est: 0.25 (-32.0%)
|
0.19
est: 0.97 (-80.4%)
|
1.31
1.31 – 1.31
+35.1% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-11 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-08 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-06 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-30 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-29 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Daoxiong Hu | Deputy GM & Director | — | male |
| Hong Xian Shen | Accounting Supervisor | — | — |
| Ningyu Di | Deputy GM & Director | — | male |
| Ying Zhang | Secretary to the Board | — | female |
| Zheng Zhong Yin | General Manager | — | male |
| Zhi Yuan Cheng | Financial Director | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 001255.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
